James Rosa has become vice president, strategic development of Evergreen, Colo.-based CeMines, a privately held company that is developing molecular fingerprinting technology for cancer diagnostics and therapeutics. Rose was previously director of business development at Transat Technologies. Before that, he held a variety of positions at Intel. He has also worked at Gambro Renal Products, Presearch, Wespace, Goodyear Aerospace, and Raytheon.